Primary oculoleptomeningeal transthyretin amyloidosis with subarachnoid hemorrhages, visual loss, and heart and skin amyloid deposits
Neurological Sciences · 2026
DOI: 10.1007/s10072-025-08624-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurological Sciences, 2026. Verfasst von Alessandro Francia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Ospedale Luigi Sacco, Milan, Italy. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Subarachnoid Hemorrhage, Vision Disorders. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Primary oculoleptomeningeal amyloidosis (OLMA) is a rare hereditary transthyretin (TTR) amyloidosis (ATTRv) associated with specific TTR variants. p.Arg54Gly is characterized by an ocular phenotype with vitreous opacities and chronic open-angle glaucoma. METHODS: We report for the first time the occurrence of subarachnoid hemorrhages, seizures, cardiac and skin amyloid deposits in a patient with OLMA carrying the TTR p.Arg54Gly variant. RESULTS: A 40-year-old man with a history of visual loss presented with altered mental status, right hemiplegia, and global aphasia, followed by a gradual recovery over 5 days. Brain MRI with gadolinium showed diffuse leptomeningeal enhancement and small convexity subarachnoid hemorrhagic foci. Optical coherence tomography showed spindle needle-shaped hyperreflective formations over the inner limiting membrane. Cardiac scintigraphy and skin biopsy stainings were positive. He had further neurological episodes despite Tafamidis treatment. DISCUSSION: Our case expands the phenotypic spectrum of the pathogenic p.Arg54Gly TTR gene variant, demonstrating intracranial hemorrhages, seizures with a prolonged post-ictal state, and amyloid deposits in heart and skin. OLMA may mimic various infectious, inflammatory and malignant conditions affecting the central nervous system. An accurate ophthalmological evaluation may help narrowing down broad differential diagnoses and raise the suspicion of uncommon systemic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, Ospedale Luigi Sacco, Milan, Italy.
- Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
- Eye Clinic, Department of Biomedical and Clinical Sciences, Ospedale Luigi Sacco, University of Milan, Milan, Italy.
- Save Sight Institute, University of Sidney, Sidney, NSW, Australia.
- Neuropathology Unit, Department of Diagnostics and Applied Technologies, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Unit of Rare Neurological Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Zitieren
APA
Francia, A., Mattavelli, D., Braga, M., Zicarelli, F., Invernizzi, A., Marucci, G., Fenu, S., Pareyson, D., & Pantoni, L. (2026). Primary oculoleptomeningeal transthyretin amyloidosis with subarachnoid hemorrhages, visual loss, and heart and skin amyloid deposits. Neurological Sciences. https://doi.org/10.1007/s10072-025-08624-7
Vancouver
Francia A, Mattavelli D, Braga M, Zicarelli F, Invernizzi A, Marucci G, et al. Primary oculoleptomeningeal transthyretin amyloidosis with subarachnoid hemorrhages, visual loss, and heart and skin amyloid deposits. Neurological Sciences. 2026. doi:10.1007/s10072-025-08624-7
BibTeX
@article{Francia2026,
author = {Francia, Alessandro and Mattavelli, Daniele and Braga, Massimiliano and Zicarelli, Federico and Invernizzi, Alessandro and Marucci, Gianluca and Fenu, Silvia and Pareyson, Davide and Pantoni, Leonardo},
title = {Primary oculoleptomeningeal transthyretin amyloidosis with subarachnoid hemorrhages, visual loss, and heart and skin amyloid deposits},
journal = {Neurological Sciences},
year = {2026},
doi = {10.1007/s10072-025-08624-7}
}
EUVIMED